These findings are particularly relevant given the connection between eIF1A mutations and certain cancers, including ovarian carcinoma (Etemadmoghadam et al, 2017; Ewens et al, 2014; Karunamurthy et al, 2016), emphasizing the need for further exploration of their therapeutic applications. Here, EIF1 is linked to cancer.